Distinct epithelial growth factor receptor mutation profile in non-small-cell lung cancer patients from the Xuanwei area of China.
The Xuanwei county in China has a high incidence of lung cancer and related mortality. Previous studies have suggested that these cases may be associated with a distinctive pattern of mutations in the epithelial growth factor receptor (EGFR) gene. In this retrospective study, we investigated the mutation profile of EGFR in non-small-cell lung cancer (NSCLC) tissues from patients in Xuanwei, and the associated clinicopathological characteristics. Specimens from 258 consecutive patients with lung cancer (90 from Xuanwei and 168 from other areas of Yunnan province) were subjected to amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) to detect EGFR mutations. In 67 specimens from Xuanwei, the results were confirmed by direct DNA sequencing for EGFR mutations. Immunohistochemistry (IHC) for the echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion protein was performed on all specimens from Xuanwei. We observed that Xuanwei patients presented with distinctive clinicopathological characteristics, including female gender predominance, younger age, higher rate of lymph node metastasis, higher rate of adenocarcinoma histological classification and lower disease stage, and a low rate of the 'classical' mutations on EGFR exons 19 and 21 compared with non-Xuanwei patients (7.8 and 21.6% vs. 49.3 and 39.7%, respectively; P<0.05 for combined data). However, a significantly higher percentage of Xuanwei patients harbored co-mutation of EGFR exons 18 and 20 compared with non-Xuanwei patients (45.1 vs. 4.1%, respectively; P<0.0001). Specimens from 2 Xuanwei patients (2.2%) were positive for the EML4-ALK fusion protein; by IHC, neither harbored EGFR mutations. There was no obvious association between EGFR mutations and disease stage or lymph node involvement. Thus, NSCLC patients in Xuanwei presented with a unique EGFR profile of high rates of co-mutation of exons 18 and 20, and low rates of exon 19 or 21 mutations when compared with patients from other areas in the same province, whereas only few of the tumors from Xuanwei patients expressed the EML4-ALK oncogene.
Department of Pathology, Yunnan Provincial Tumor Hospital, Kunming, Yunnan 650100, P.R. China.
Yun
Y
Chen
Department of Pathology, Yunnan Provincial Tumor Hospital, Kunming, Yunnan 650100, P.R. China.
Lijuan
L
Ye
Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Rebecca Rongrong
RR
Stanford
Department of Pathology, Yunnan Provincial Tumor Hospital, Kunming, Yunnan 650100, P.R. China.
Dongfang
D
Zhang
Department of Pathology, Yunnan Provincial Tumor Hospital, Kunming, Yunnan 650100, P.R. China.
Xingsong
X
Zhang
Department of Pathology, Yunnan Provincial Tumor Hospital, Kunming, Yunnan 650100, P.R. China.
Wanli
W
Wei
Xuanwei; amplification refractory mutation system polymerase chain reaction; echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase; environmental factors; epidermal growth factor receptor; household coal burning; lung cancer